Amalgamated Bank Sells 19,573 Shares of Leidos Holdings, Inc. (NYSE:LDOS)

Amalgamated Bank lessened its position in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 41.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,550 shares of the aerospace company’s stock after selling 19,573 shares during the period. Amalgamated Bank’s holdings in Leidos were worth $4,019,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Franklin Resources Inc. increased its position in Leidos by 18.3% during the 4th quarter. Franklin Resources Inc. now owns 74,671 shares of the aerospace company’s stock worth $8,082,000 after purchasing an additional 11,576 shares in the last quarter. Twin Tree Management LP acquired a new position in Leidos during the 1st quarter worth approximately $2,512,000. Leeward Investments LLC MA increased its position in Leidos by 4.9% during the 1st quarter. Leeward Investments LLC MA now owns 166,069 shares of the aerospace company’s stock worth $21,770,000 after purchasing an additional 7,703 shares in the last quarter. CHURCHILL MANAGEMENT Corp acquired a new position in Leidos during the 1st quarter worth approximately $1,900,000. Finally, Advisors Asset Management Inc. increased its position in Leidos by 97.2% during the 1st quarter. Advisors Asset Management Inc. now owns 12,904 shares of the aerospace company’s stock worth $1,692,000 after purchasing an additional 6,360 shares in the last quarter. Institutional investors own 76.12% of the company’s stock.

Insider Activity

In other news, Director Robert C. Kovarik, Jr. sold 1,059 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $145.23, for a total value of $153,798.57. Following the completion of the transaction, the director now directly owns 7,455 shares in the company, valued at $1,082,689.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Gary Stephen May sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $144.02, for a total value of $144,020.00. Following the completion of the transaction, the director now directly owns 11,264 shares in the company, valued at $1,622,241.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert C. Kovarik, Jr. sold 1,059 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $145.23, for a total transaction of $153,798.57. Following the completion of the transaction, the director now owns 7,455 shares of the company’s stock, valued at $1,082,689.65. The disclosure for this sale can be found here. 0.96% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Bank of America upped their price target on shares of Leidos from $160.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Royal Bank of Canada increased their price objective on shares of Leidos from $140.00 to $145.00 and gave the stock a “sector perform” rating in a research report on Wednesday, July 31st. Truist Financial increased their target price on shares of Leidos from $165.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, September 5th. Wells Fargo & Company increased their target price on shares of Leidos from $168.00 to $172.00 and gave the stock an “overweight” rating in a research note on Thursday, August 1st. Finally, TD Cowen raised their price objective on shares of Leidos from $155.00 to $166.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $163.08.

Leidos Price Performance

LDOS opened at $157.06 on Monday. The company has a market capitalization of $21.24 billion, a price-to-earnings ratio of 67.70, a PEG ratio of 1.38 and a beta of 0.70. The company has a quick ratio of 1.11, a current ratio of 1.21 and a debt-to-equity ratio of 0.91. The firm has a 50-day moving average price of $151.25 and a 200-day moving average price of $143.09. Leidos Holdings, Inc. has a twelve month low of $89.22 and a twelve month high of $159.10.

Leidos (NYSE:LDOS) last posted its earnings results on Tuesday, July 30th. The aerospace company reported $2.63 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.36. The firm had revenue of $4.13 billion during the quarter, compared to the consensus estimate of $4.06 billion. Leidos had a net margin of 2.72% and a return on equity of 28.40%. The company’s revenue was up 7.7% on a year-over-year basis. During the same quarter last year, the company earned $1.80 earnings per share. Equities analysts expect that Leidos Holdings, Inc. will post 8.95 EPS for the current year.

Leidos Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 27th. Stockholders of record on Friday, September 13th will be paid a $0.38 dividend. The ex-dividend date is Friday, September 13th. This represents a $1.52 annualized dividend and a dividend yield of 0.97%. Leidos’s payout ratio is 65.52%.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.